The Prevalence of Low Insulin Responders to Oral Glucose Load Among Groups with Various Patterns of Family History of Diabetes

Abstract

The prevalence of low insulin responders was assessed in non-diabetic subjects with various patterns of family history of diabetes. Subjects were divided into five groups: group A, without any family history of diabetes among all known relatives; group B, with diabetes among parents and/or siblings; group C, with one diabetic parent; group D, with two diabetic parents; and group E, non-diabetic co-twins of monozygotic twins with diabetes. Except twins, the type of diabetes in the family was not defined. They were examined by 1 00 g oral glucose tolerance test (OGTI) except for group E in which SO g or 75 g OGTI were also used. Insulin response was evaluated by the insulinogenic index, the ratio of increment of serum insulin to that of plasma glucose (mg dl-1 ) 30 min after the oral glucose load. The low insulin responders had a lower insulinogenic index below 0.5 in the case of 100 g OGTI, and below 0.35 and 0.4 in the case of 50 g and 75 g OGTI. Groups with a family history of diabetes (8, C, and D) had significantly lower insulinogenic indices than group A without a family history of diabetes. The prevalence of low insulin responders was significantly higher in subjects with a strong family history of non-insulin-dependent diabetes mellitus (NIDDM), such as subjects with two diabetic parents and monozygotic co-twins of NIDDM patients. In group A, low insulin responders were more prevalent in older subjects, while in group D, they were also frequent in younger subjects. These results suggest that a low insulin response has a genetic basis and is a preclinical feature in subjects with genetic pre-disposition to NIDDM. KEY WORDS Insulin response OGTI

Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited. Metabolic studies on offspring of diabetic probands.

“…These findings have important implications for genetic studies. Low insulin response to oral glucose has been suggested to have a genetic basis (53,54). Although the reduced ␤ cell mass in our study did not explain low insulin response in the offspring of probands with insulin deficient phenotype, other mechanisms, however, could be involved.…”

A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility

“…For example, glucokinase defects (MODY 2) that have been shown to have a defective second-phase insulin secretion while ®rstphase insulin secretion is preserved [33] should show a normal or near normal DI arg and I GLP-1 . Furthermore, abnormalities of the insulin response to oral glucose, which is a sum effect of glucose and incretins, including GLP-1 [34], as secretagogues shows a strong genetic basis [35]. This would include defects resulting in abnormalities speci®c for incretin-stimulated insulin secretion that have yet to be de®ned.…”

Prediction of antidiabetic effect after gastrectomy with Roux-en-Y reconstruction in patients with gastric cancer and type 2 diabetes

“…[11] The IGI was calculated as follows: (30 minutes insulin [μU/mL] − fasting insulin [μU/ mL])/(30 minutes glucose [mg/dL] − fasting glucose [mg/dL]), and was used to estimate early phase insulin secretion. [16,17] We defined the remission of T2DM as HbA1c levels <6.0% without drug treatment, and patients satisfying this definition were classified into the remission group. [18,19] Data were presented as medians (interquartile range) for continuous variables and as numbers or percentages for categorical variables.…”